UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

__________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 6, 2007

 

AngioDynamics, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

000-50761

11-3146460

 

 

 

(State or Other Jurisdiction
of Incorporation)

(Commission File

Number)

(IRS Employer

Identification No.)

 

 

 

603 Queensbury Avenue, Queensbury, New York

12804

(Address of Principal Executive Offices)

(Zip Code)

 

 

 

(518) 798-1215

(Registrant’s telephone number, including area code)

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))


 

Item 5.02.          Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(b)          Effective June 1, 2007, Paul J. Shea resigned as Vice President of Sales to pursue other career opportunities. Mr. Shea was succeeded by John Soto, whom the Company named Vice President of Global Sales.

 

For additional information, please see the Company's June 7, 2007 press release, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ANGIODYNAMICS, INC.

 

(Registrant)

 

 

 

 

 

 

 

 

Date: June 7, 2007

By:

/s/ D. Joseph Gersuk

 

 

D. Joseph Gersuk

 

 

Chief Financial Officer

 

 

 

 

 

 

 


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

99.1

 

Press Release dated June 7, 2007.